The table below shows Bluejay Diagnostics, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$6.05M
-$7.82M
-$8.31M
-$7.74M
-$4.37M
-$508.71K
Capital expenditure
$173.74K
$306.78K
$704.17K
$1.20M
$23.95K
-
Investing cash flow
-$173.74K
-$306.78K
-$704.17K
-$1.20M
-$23.95K
-
Dividends paid
-
-
-
-
BJDX operating cash flow (10-K history)
Bluejay Diagnostics, Inc. reported operating cash flow of -$6.05M for fiscal year 2025. That is up 22.6% from -$7.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$508.71K (FY 2020) to -$6.05M. Figures come from the company's audited annual reports as filed with the SEC.